Aarey Drugs & Pharmaceuticals Limited

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) is a micro-cap Healthcare company valued at ₹320 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Aarey Drugs & Pharmaceuticals Limited last traded at ₹107, modestly up 0.64% on the day.

Recent developments

On 2026-08-31, promoter holding was reported at 42.79%, with no significant changes noted in recent quarters. The company has not paid dividends despite reporting profits, which may indicate a focus on reinvestment or liquidity management.

Financial performance

The company's annual revenue fell 0.4% year-over-year, while net profit remained flat. The latest quarter saw revenue drop 56.3% compared to the same quarter a year earlier, and net profit fell 25.5% despite a slight increase in the latest fiscal year.

Valuation multiples

The stock trades at 77.0 times earnings, a premium to the Healthcare median of 32.0, 1.77 times book value.

Things to watch

The company's net profit margin narrowed by 0.0 percentage points to 0.8%, and its latest quarter revenue and net profit both fell significantly compared to the same period a year earlier. The stock is 3.7% below its 52-week high, and the company has not distributed dividends to shareholders despite reporting profits.

Where it stands

Aarey Drugs & Pharmaceuticals Ltd reported flat annual net profit and a slight decline in revenue, with the latest quarter showing a sharp drop in both metrics. The company's stock is trading below its 52-week high, and it has not paid dividends to shareholders despite repeated profits.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.